In July 2017 the MHRA approved the reclassification of atovaquone 250mg/proguanil 100mg from a POM to a P medicine for chemoprophylaxis of P.falciparum* in adults (18yrs and over) travelling for up to a maximum of 12 weeks in a malaria endemic area. The change became effective in September 2017 with Maloff Protect now available to purchase through pharmacy

*In 2016 P. falciparum represented 80% of malaria cases reported

Keys actions to take when supplying Maloff Protect :

1. Check country being visited
2. Check traveller is suitable for Maloff Protect
3. Calculate the number of tablets required
4. Advise the traveller how to take the tablets ^{(see table 1.)} 
5. Advise of potential side effects
6. Provide practice advice on bite prevention
7. Advise of symptoms of malaria and importance of early diagnosis 

Visit Maloff Protect Pharmacy Zone for supporting materials by clicking here. 

It is advisable for travellers to have a full travel health consultation including vaccinations

Numark can support you to offer a full travel clinic and  vaccination service – for more information visit Numarknet by clicking here. 

Table 1.